𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma

✍ Scribed by DE Fine Olivarius; Lock-Andersen; GRØnhØJ Larsen; Wulf; Crosby; Norval


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
499 KB
Volume
138
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

✦ Synopsis


Urocanic acid (UCA) is a major chromophore for ultraviolet (UV) radiation in the skin. On UV exposure, the naturally occurring trans-isomer converts to the cis-isomer in a dose-dependent manner. Accumulating evidence indicates that cis-UCA acts as an initiator of the UV-induced suppression of certain skin immune functions. This immunomodulation is recognized as an important factor in the development of skin cancer. In this study, pigmentation and UCA isomers were measured in 29 patients with previous basal cell carcinoma (BCC), 23 patients with previous cutaneous malignant melanoma (MM), and 32 healthy controls. Measurements were performed on UV-exposed (forehead, upper back) and UV non-exposed (buttock) skin. No significant differences in pigmentation percentage, total UCA concentration, relative (%) or absolute (nmol/cm2) cis-UCA concentration were observed between the groups in any of the body sites studied. The net production of cis-UCA after irradiation with a single test UV dose was evaluated. The relative production of cis-UCA following irradiation was significantly higher in both cancer groups when compared with the control group, while no significant difference was found between the BCC and the MM patients.


📜 SIMILAR VOLUMES


Basal cell and squamous cell carcinomas
✍ Ashfaq A. Marghoob; Johnny Slade; Thomas G. Salopek; Alfred W. Kopf; Robert S. B 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

Background. This study was designed to determine the risk of developing malignant melanoma (MM) in patients with a history of basal cell and/or squamous cell skin cancer (BCC/SCC) and to determine whether surveillance efforts can be directed toward these patients for the detection of early MMs. Met

Second primary tumors in patients with c
✍ Smita Bhatia; Lilian Estrada-Batres; Tamara Maryon; Monica Bogue; David Chu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c

The risk of subsequent primary carcinoma
✍ Maryjean Schenk; Richard K. Severson; Karen S. Pawlish 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 3 views

## Background: Carcinoma of the pancreas is the fifth leading cancer in the u.s. and has the poorest survival rate of the major malignancies. recent studies have reported an increased risk of carcinoma of the pancreas in malignant melanoma-prone kindreds and have suggested a link between malignant